Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Ganoderma lucidum extract and its component, ganoderic acid A, may effectively prevent hair loss.

Azathioprine can cause severe hair loss and low white blood cell count in lupus patients.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Compounds from Etlingera alba may help treat Triple Negative Breast Cancer.

Compound glycyrrhizin with conventional treatments is effective and safe for hair regrowth in alopecia areata.

Ritlecitinib is safe and may effectively treat alopecia areata.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Researchers found two enzymes in Avicennia marina that help produce maslinic acid and corosolic acid, which have medicinal benefits.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Skin acetyl-CoA synthesis is crucial for overall lipid balance.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Apremilast shows promise for several skin conditions but needs more research.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

A new compound shows promise as a topical treatment for hair loss.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.